Ulrike Puhlmann

Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring

Claudia Langebrake, Iris Brinkmann, Andrea Teigler‐Schlegel et al. · Cytometry Part B Clinical Cytometry · 2004 · 91 citations · Full text

Medicine, Hematology, Pathology +17

Impact of the Cyclooxygenase System on Doxorubicin-Induced Functional Multidrug Resistance 1 Overexpression and Doxorubicin Sensitivity in Acute Myeloid Leukemic HL-60 Cells

Ulrike Puhlmann, Christina Ziemann, Gudrun Ruedell et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 50 citations

Medicine, Oncology, Pharmacology +13

Concomitant aberrant overexpression of RUNX1 and NCAM in regenerating bone marrow of myeloid leukemia of Down's syndrome.

Claudia Langebrake, Jan‐Henning Klusmann, Kristina Wortmann et al. · PubMed · 2006 · 22 citations

Medicine, Hematology, Oncology +17

[Relapse prognosis following reduction of drugs in epilepsy treatment].

D Janz, Andreas Kern, Mössinger Hj et al. · PubMed · 1983 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +9